Rockefeller Capital Management’s Pulmonx LUNG Stock Holding History

Rockefeller Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-272	Closed	-$4K	–	4174
2022 Q2	$4K	Buy	+272	New	+$5.6K	﹤0.01%	3556

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's LUNG Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Pulmonx (LUNG) in Q3 2022, closing a stake of 272 shares — an estimated $4K sold.

Rockefeller Capital Management first reported a position in LUNG in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

Rockefeller Capital Management reported no remaining Pulmonx position as of Q3 2022 after selling out during the quarter.
Rockefeller Capital Management sold 272 Pulmonx shares in Q3 2022, an estimated $4K.
Rockefeller Capital Management first reported a position in Pulmonx in Q2 2022 and held it in 1 quarter.
Rockefeller Capital Management's Pulmonx position peaked at $4K in Q2 2022.
104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.